You have 9 free searches left this month | for more free features.

14-005

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Health Volunteer Trial ([14C]Hemay005)

Not yet recruiting
  • Health Volunteer
  • (no location specified)
Jul 19, 2022

Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

Recruiting
  • Mycobacterium Infections, Nontuberculous
  • Birmingham, Alabama
  • +172 more
Jan 23, 2023

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (BEA 2180 BR, Tiotropium Bromide, Placebo)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • BEA 2180 BR
  • +2 more
  • Jasper, Alabama
  • +177 more
Jul 30, 2021

Pain, Tumors, Chronic Pain Trial in Worldwide (Cebranopadol, Morphine Prolonged Release)

Terminated
  • Pain
  • +2 more
  • Vienna, Austria
  • +41 more
Jul 13, 2021

Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)

Recruiting
  • Non-Cystic Fibrosis Bronchiectasis
  • Brensocatib 10 mg
  • +2 more
  • Birmingham, Alabama
  • +416 more
Jan 24, 2023

QUILT-3.032 and of QUILT-2.005

Terminated
  • Pharmacokinetics
  • BCG in Combination with N-803
  • N-803 alone
  • Los Angeles, California
  • +5 more
Jan 20, 2021

COVID-19 Trial in India (101-PGC-005, Dexamethasone)

Recruiting
  • COVID-19
  • Srikakulam, Andhra Pradesh, India
  • +4 more
Jan 31, 2023

Multiple Myeloma, Renal Failure Trial in Worldwide (Data collection)

Active, not recruiting
  • Multiple Myeloma
  • Renal Failure
  • Data collection
  • Alger, Algeria
  • +32 more
Feb 7, 2022

Sepsis Trial in Nanjing (SY-005, Placebo)

Recruiting
  • Sepsis
  • Nanjing, Jiangsu, China
    Zhongda Hospital,Affiliated to Southeast University
Feb 27, 2022

Endometrial Cancer Trial (MK-2870, Doxorubicin, Paclitaxel)

Not yet recruiting
  • Endometrial Cancer
  • MK-2870
  • +2 more
  • (no location specified)
Nov 10, 2023

Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,

Terminated
  • Hematopoietic Stem Cell Transplantation
  • +4 more
  • Duarte, California
  • +3 more
Oct 18, 2022

Psoriasis Vulgaris Trial in United States (Calcipotriene/ betamethasone dipropionate topical foam, 0.005%/0.064%, Enstilar® foam

Completed
  • Psoriasis Vulgaris
  • Calcipotriene/ betamethasone dipropionate topical foam, 0.005%/0.064%
  • +2 more
  • Encinitas, California
  • +29 more
Aug 17, 2020

ASCVD, Risk Factor, Cardiovascular, Elevated Cholesterol Trial in Worldwide (Inclisiran Sodium, Placebo)

Completed
  • ASCVD
  • +2 more
  • Inclisiran Sodium
  • Placebo
  • Chomutov, Czechia
  • +69 more
Aug 3, 2020

Amyotrophic Lateral Sclerosis Trial in Boston (SLS-005, Matching Placebo)

Enrolling by invitation
  • Amyotrophic Lateral Sclerosis
  • Boston, Massachusetts
    Healey Center for ALS at Mass General
Mar 22, 2022

Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide

Recruiting
  • Uterine Cervical Neoplasms
  • +10 more
  • Pembrolizumab/Vibostolimab Co-Formulation
  • +11 more
  • Anchorage, Alaska
  • +65 more
Jan 27, 2023

Schizophrenia, Schizoaffective Disorder Trial (LYN-005, Risperidone)

Not yet recruiting
  • Schizophrenia
  • Schizoaffective Disorder
  • (no location specified)
Mar 24, 2023

Type2 Diabetes Trial in United States (Omnipod 5 Automated Glucose Control System)

Recruiting
  • Type2 Diabetes
  • Omnipod 5 Automated Glucose Control System
  • Santa Barbara, California
  • +6 more
Apr 19, 2023

Covid19 Trial in Japan (Novaferon, Placebo)

Recruiting
  • Covid19
  • Novaferon
  • Placebo
  • Chiba, Japan
  • +21 more
Jan 13, 2022

Glucocorticoids Toxicity, COVID-19, Infectious Disease Trial in Bangalore (101-PGC-005)

Active, not recruiting
  • Glucocorticoids Toxicity
  • +3 more
  • Bangalore, Karnataka, India
    ICBio Clinical Research Pvt. Ltd.
Dec 13, 2022

Alzheimer's Disease Trial in United States (MK-1942, Donepezil, Placebo)

Completed
  • Alzheimer's Disease
  • Rogers, Arkansas
  • +3 more
May 24, 2022

MPS I, MPS1-S, MPS1-HS Trial in Porto Alegre, London, Salford (SIG-005 (hIDUA Producing Spheres))

Withdrawn
  • MPS I
  • +2 more
  • SIG-005 (hIDUA Producing Spheres)
  • Porto Alegre, Brazil
  • +2 more
Dec 16, 2022

COPD, COPD Trial in Edegem, Erpent (GP MDI (PT001) 14.4 µg, FF MDI (PT005) 9.6 µg)

Completed
  • COPD, Chronic Obstructive Pulmonary Disease
  • GP MDI (PT001) 14.4 μg
  • FF MDI (PT005) 9.6 μg
  • Edegem, Belgium
  • +1 more
Jun 28, 2019

Wounds and Injuries, Lacerations, Surgical Incision Trial in Worldwide (MAR-CUTIS, Dermabond Advanced)

Terminated
  • Wounds and Injuries
  • +2 more
  • MAR-CUTIS
  • Dermabond Advanced
  • Amiens, France
  • +18 more
Aug 10, 2020

Impacted Third Molar Tooth, Impacted Tooth Trial in Istanbul (Single-Session Bilateral Mandibular Third Molar Extraction,

Completed
  • Impacted Third Molar Tooth
  • Impacted Tooth
  • Single-Session Bilateral Mandibular Third Molar Extraction
  • Two-Session Bilateral Mandibular Third Molar Extraction
  • Istanbul, Turkey
    Marmara University School of Dentistry
Apr 6, 2023

Pulmonary Arterial Hypertension Trial in Worldwide (Sotatercept, Placebo)

Recruiting
  • Pulmonary Arterial Hypertension
  • Phoenix, Arizona
  • +137 more
Jan 27, 2023